Use of VISIA-CR Generation 5 in Aesthetic Skin Assessment: A Single-Case Review

VISIA-CR第五代在皮肤美学评估中的应用:单例回顾

阅读:1

Abstract

Traditional evaluations of nonsurgical aesthetic treatments often rely on clinical photography and patient-reported outcomes, which are subjective and may overlook subtle or subsurface changes. Advanced imaging technologies, such as the VISIA-CR system, have increased objectivity; however, earlier generations provided limited parameters and lacked integrated analytics. The aim of this review was to illustrate the enhanced capabilities of the VISIA-CR Generation 5 system (VISIA-CR 5) and explore its clinical relevance through a single-case example. A 49-year-old female with Fitzpatrick skin phototype III underwent a combined treatment with intense pulsed light, a fractionated 1927 nm laser, and a dual-wavelength 1470/2940 nm laser. Standardized VISIA-CR 5 imaging was performed at baseline and 3 months. The system captured multispectral images and quantified 8 skin features (visible spots, brown spots, red spots, ultraviolet (UV) spots, texture, pores, porphyrins, and wrinkles) using expanded multiparameter analytics. The VISIA-CR 5 provided multidimensional assessment beyond conventional visual evaluation by quantifying feature intensity, background skin tone, and relative contrast. Although the mean intensity of visible, brown, and UV spots appeared darker at 3 months, contrast-based analysis indicated improved skin tone uniformity. The system also detected reduced fractional area alongside increased count for visible and UV spots, suggesting fragmentation of larger spots rather than proliferation, a level of detail unattainable with traditional methods. This case demonstrates that the VISIA-CR 5 can provide detailed imaging and integrated analytics that support comprehensive, objective evaluation of aesthetic treatment outcomes. Its expanded parameters facilitate detection of subtle, clinically relevant changes and highlight its potential utility in clinical research and practice. Level of Evidence: 4 (Therapeutic).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。